Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
News
All NewsCompaniesIndexesCurrency / ForexCommoditiesCryptocurrenciesETFInterest RatesEconomyThemesSectors 

Medical device makers see little impact from Fiona on Puerto Rico operations

09/23/2022 | 07:10am EST
FILE PHOTO: Hurrican Fiona landfalls in Puerto Rico

(Reuters) - Medical device companies and some drugmakers with manufacturing operations in Puerto Rico said they do not expect meaningful disruption from Hurricane Fiona, which knocked out power for over 3 million people and caused flooding and landslides on the island.

The U.S. Food and Drug Administration, which worked with companies to prevent shortages of drugs and medical devices after Hurricane Maria battered the medical manufacturing hub in 2017, said it is in discussion with companies it regulates there regarding any impact on supplies.

Most companies Reuters spoke to, including Baxter International, said they had initially either temporarily halted operations or were running their plants on generators since Fiona struck on Sunday.

None said they expected supplies to the United States to be significantly disrupted by the storm, in part due to infrastructure changes, such as building up their generator power, following Hurricane Maria.

The electricity grid on the island is owned by bankrupt state-run Puerto Rico Electric Power Authority (PREPA) and is now operated by LUMA Energy, a private joint venture of Canadian energy firm ATCO Ltd and U.S. energy contractor Quanta Services.

While the pace of power restoration has been much faster than following the devastation of Maria, an estimated 1 million homes and businesses remain without power. Baxter, which makes small bags for intravenous medication, clinical nutrition products and inhaled anesthetics in Puerto Rico, said its facilities have "sustained little to no damage" from the storm.

By Thursday, Baxter had restarted operations and was running at normal, pre-hurricane levels, spokesperson Lauren Russ said.

The company took a $70 million revenue hit after Hurricane Maria in 2017, spurring it to diversify manufacturing of key products.

Ahead of hurricane season, the company now builds up supplies of some products and stores much of it on the U.S. mainland, Russ said, adding that Baxter had good inventory levels for most products produced in Puerto Rico and the Dominican Republic for U.S. customers.

Integra Lifesciences and Abbott Laboratories also upgraded back-up generators and communication capabilities and shored up infrastructure at plants such as improvements to roofs and pipes, their spokespeople said.

"Most MedTech companies are more prepared with greater redundancy" than when Maria hit, J.P Morgan analyst Robbie Marcus in a research note.

Spokespeople for other medical equipment companies including Becton Dickinson, Medtronic, Edwards Lifesciences and Stryker also said they were not seeing a major impact to operations from Hurricane Fiona due to measures undertaken following Maria.

Drugmakers with plants in Puerto Rico said they have been able to keep up production and supplies as well.

Johnson & Johnson said operations were restored at all its sites in Puerto Rico by Wednesday.

AbbVie's facilities are intact and operational and unlikely to see any patient impact or product shortages due to Fiona, according to a person familiar with the company's operations who asked not to be named.

Eli Lilly and Co has not experienced any disruptions to its site or supply, spokesperson Molly McCully said.

(Reporting by Leroy Leo and Khushi Mandowara in Bengaluru; additional reporting by Michael Erman; editing by Caroline Humer and Bill Berkrot)

By Leroy Leo and Khushi Mandowara


ę Reuters 2022
Stocks mentioned in the article
ChangeLast1st jan.
ABBOTT LABORATORIES 1.97% 107.05 Delayed Quote.-25.12%
ATCO LTD. 1.52% 43.02 Delayed Quote.0.26%
BAXTER INTERNATIONAL INC. 1.66% 56.215 Delayed Quote.-35.53%
BECTON, DICKINSON AND COMPANY 3.10% 248.395 Delayed Quote.-3.43%
EDWARDS LIFESCIENCES CORPORATION 2.45% 76.7 Delayed Quote.-42.22%
ELI LILLY AND COMPANY 0.80% 367.17 Delayed Quote.32.42%
INTEGRA LIFESCIENCES HOLDINGS CORPORATION 1.38% 54.33 Delayed Quote.-19.85%
MEDTRONIC PLC 2.66% 78.5 Delayed Quote.-26.41%
QUANTA SERVICES 3.07% 148.92 Delayed Quote.26.07%
Latest news "Economy"
03:48pFDA pulls U.S. authorization for Eli Lilly's COVID drug bebtelovimab
RE
03:47pBritish pound on course for 5.4% monthly gain against us dollar,…
RE
03:46p30-Year Treasury Yield Falls to 3.821% This Month -- Data Talk
DJ
03:46pSilicon Valley leaders welcome Elon Musk's management of Twitter
RE
03:45pU.N. says deal close on resuming Russia ammonia exports via Ukraine
RE
03:45pAussie on track for 6.2% gain against us dollar this month, best…
RE
03:45p10-Year Treasury Yield Falls to 3.699% This Month -- Data Talk
DJ
03:45p2-Year Treasury Yield Falls to 4.372% This Month -- Data Talk
DJ
03:44pEuro on course for monthly gain of 5.5% against us dollar, best…
RE
03:43pUs dollar on track for monthly loss of 7.4% against japanese yen…
RE
Latest news "Economy"